Simultaneous quantification of alprazolam, 4- and α-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry

被引:17
作者
Allqvist, A [1 ]
Wennerholm, A [1 ]
Svensson, JO [1 ]
Mirghani, RA [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, S-14186 Huddinge, Sweden
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 814卷 / 01期
关键词
liquid chromatography-mass spectrometry alprazolam; 4-hydroxyalprazolam; alpha-hydroxyalprazolam; pharmacokinetics;
D O I
10.1016/j.jchromb.2004.10.012
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and specific method was developed for quantification of alprazolam and its two metabolites 4-hydroxyalprazolam and alpha-hydroxyalprazolam in plasma. The work up procedure was solid phase extraction. Liquid chromatography-mass spectrometry (LC-MS) was used for separation, detection and quantification of the analytes. The limit of quantitation (LOQ) was 0.05 ng/mL for alprazolam and die two metabolites. The extraction recovery was more than 82% for alprazolam and its metabolites. The within- and between-assay coefficients of variation were in the range of 1.9-17.9%. The method was used for determination of the pharmacokinetics parameters of alprazolam and its two metabolites in healthy Caucasian subjects who ingested 1 mg of alprazolam. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 17 条
[1]   NORMAL-PHASE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ALPRAZOLAM IN HUMAN-SERUM [J].
ADAMS, WJ ;
BOMBARDT, PA ;
BREWER, JE .
ANALYTICAL CHEMISTRY, 1984, 56 (09) :1590-1594
[2]  
CAIRNS ER, 1994, J ANAL TOXICOL, V18, P1
[3]   Quantitation of alprazolam and α-hydroxyalplazolam in human plasma using liquid chromatography electrospray ionization MS-MS [J].
Crouch, DJ ;
Rollins, DE ;
Canfield, DV ;
Andrenyak, DM ;
Schulties, JE .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1999, 23 (06) :479-485
[4]  
Goldnik A, 1994, Acta Pol Pharm, V51, P311
[5]   Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily [J].
Gorski, JC ;
Jones, DR ;
Hamman, MA ;
Wrighton, SA ;
Hall, SD .
XENOBIOTICA, 1999, 29 (09) :931-944
[6]   GAS-CHROMATOGRAPHIC ANALYSIS OF ALPRAZOLAM IN PLASMA - REPLICABILITY, STABILITY AND SPECIFICITY [J].
GREENBLATT, DJ ;
JAVAID, JI ;
LOCNISKAR, A ;
HARMATZ, JS ;
SHADER, RI .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 534 :202-207
[7]   CLINICAL PHARMACOKINETICS OF ALPRAZOLAM - THERAPEUTIC IMPLICATIONS [J].
GREENBLATT, DJ ;
WRIGHT, CE .
CLINICAL PHARMACOKINETICS, 1993, 24 (06) :453-471
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ALPRAZOLAM IN POSTMORTEM BLOOD USING SOLID-PHASE EXTRACTION [J].
HALL, MA ;
ROBINSON, CA ;
BRISSIE, RM .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1995, 19 (06) :511-513
[9]   In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans [J].
Hirota, N ;
Ito, K ;
Iwatsubo, T ;
Green, CE ;
Tyson, CA ;
Shimada, N ;
Suzuki, H ;
Sugiyama, Y .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2001, 22 (02) :53-71
[10]  
Hold KM, 1996, J MASS SPECTROM, V31, P1033